Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stebbins

Showing results (1081-1090 of 1,116) with videos related to

Pageof 112
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.
Clinical Pharmacology and Therapeutics|April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Science Translational Medicine|October 1, 2020
Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetaseSumiti Vinayak, Rajiv S Jumani, Peter Miller, et al.
American Journal of Infection Control|March 16, 2010
Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the researchAllison E Aiello, Rebecca M Coulborn, Tomas J Aragon, et al.
Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesMichael Hedvat, Luni Emdad, Swadesh K Das, et al.
Clinical Parkinsonism & Related Disorders|January 21, 2026
Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleGuido Alves, Yvonne Stavland Sørenes, Veslemøy Hamre Frantzen, et al.
Parkinsonism & Related Disorders|October 23, 2016
Knowledge gaps and research recommendations for essential tremorFranziska Hopfner, Dietrich Haubenberger, Wendy R Galpern, et al.
Journal of the American Heart Association|February 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular DiseaseGuillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, et al.
Neuromuscular Disorders : NMD|November 10, 2019
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE studyDarryl C De Vivo, Enrico Bertini, Kathryn J Swoboda, et al.
Pageof 112

Showing results (1081-1090 of 1,116) with videos related to

Sort By:
Pageof 112
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.
Clinical Pharmacology and Therapeutics|April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Science Translational Medicine|October 1, 2020
Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetaseSumiti Vinayak, Rajiv S Jumani, Peter Miller, et al.
American Journal of Infection Control|March 16, 2010
Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the researchAllison E Aiello, Rebecca M Coulborn, Tomas J Aragon, et al.
Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesMichael Hedvat, Luni Emdad, Swadesh K Das, et al.
Clinical Parkinsonism & Related Disorders|January 21, 2026
Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleGuido Alves, Yvonne Stavland Sørenes, Veslemøy Hamre Frantzen, et al.
Parkinsonism & Related Disorders|October 23, 2016
Knowledge gaps and research recommendations for essential tremorFranziska Hopfner, Dietrich Haubenberger, Wendy R Galpern, et al.
Journal of the American Heart Association|February 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular DiseaseGuillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, et al.
Neuromuscular Disorders : NMD|November 10, 2019
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE studyDarryl C De Vivo, Enrico Bertini, Kathryn J Swoboda, et al.
Pageof 112